Fredrik Alpsten

Fredrik Alpsten is a declared insider at 2 companies (board member); the most frequent names are Biovica International AB and Prolight Diagnostics AB (publ). We count 8 filings; the first trade dates from 3 July 2025 and the latest from 10 September 2026.

On the market, this insider has only ever bought: 6 purchases, €98k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at 4 purchases and no sales.

A typical purchase (the median) is worth €18k. Relative to company size, the median is 0.19% of market cap (5 purchases with a known value). Clusters matter here: 3 out of 6 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

The latest filing, published on 10 September 2026, reports an open-market purchase of €15k in Biovica International AB. The median gap between trade and publication is zero days: most filings appear on the same day. Under the Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.